{"id":19370066,"date":"2023-11-12T17:06:47","date_gmt":"2023-11-12T22:06:47","guid":{"rendered":"https:\/\/allergyasthmanetwork.org\/?p=19370066"},"modified":"2025-06-07T10:51:55","modified_gmt":"2025-06-07T14:51:55","slug":"usasthma-summit-2023","status":"publish","type":"post","link":"https:\/\/allergyasthmanetwork.org\/news\/usasthma-summit-2023\/","title":{"rendered":"USAsthma Summit 2023: Is Asthma Remission Possible?"},"content":{"rendered":"<p><iframe title=\"USAsthma Summit 2023\" width=\"720\" height=\"405\" src=\"https:\/\/www.youtube.com\/embed\/vD7P_d5OLxA?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/p>\n\n\n\n<p><b>Nov. 12, 2023<\/b><\/p>\n\n\n\n<p>Can asthma go into remission? The success of biologic medications has led many allergists and pulmonologists to consider it a possibility. Asthma remission was among the key issues discussed at the 9th annual USAsthma Summit, held on Nov. 10, 2023 in Anaheim, California.<\/p>\n\n\n\n<p>Biologics have proven to be a game-changing treatment for many people with moderate to severe asthma. Six different biologics are available on the market.<\/p>\n\n\n\n<p>\u201cWe are actually finding people under well-enough control that we can now define clinical remission,\u201d says Kathleen May, MD, ACAAI President. \u201cI don\u2019t think we\u2019ve ever been to a point where we could even begin to make a definition for clinical remission. So this is exciting.<\/p>\n\n\n\n<p>\u201cBut this is just a starting point. The idea for this definition is more for research, to follow these patients along. It is not clinically applicable yet. But we will be looking at this over time and refining it to determine how we can define remission.\u201d<\/p>\n\n\n\n<p>Dr. May went into more detail about the potential for asthma remission during a presentation at the USAsthma Summit. Check out more of her presentation below.<\/p>\n\n\n\n<p>The USAsthma Summit is hosted by Allergy &amp; Asthma Network each year. It is timed to coincide with the ACAAI Annual Scientific Meeting. More than 60 people attended the Summit in person and another 350+ joined our interactive livestream.<\/p>\n\n\n\n<p>The USAsthma Summit provides an up-to-date look at the state of asthma care in the United States. Each year, the Summit brings together\u2026<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>asthma coalitions<\/li>\n\n\n\n<li>state asthma programs<\/li>\n\n\n\n<li>doctors<\/li>\n\n\n\n<li>school nurses<\/li>\n\n\n\n<li>community health workers<\/li>\n\n\n\n<li>asthma patients and their caregivers<\/li>\n\n\n\n<li>patient advocates<\/li>\n\n\n\n<li>key stakeholders in asthma care<\/li>\n<\/ul>\n\n\n\n<p>During the Summit, presenters advanced Guidelines-based asthma care. They also discussed best practices and lessons learned from U.S. asthma programs. Patients and caregivers were also in attendance. They shared their stories of living with asthma.<\/p>\n\n\n\n<p>\u201cIn the last 30 years, there has been so much innovation and science for people who are living with asthma,\u201d says Lynda Mitchell, CEO of Allergy &amp; Asthma Network. \u201cThere are new options and treatments that didn\u2019t exist 30 years ago \u2013 like biologics, which are miracle drugs for many people with severe asthma. We have better guidelines for asthma management and education opportunities so people who care for those with asthma can instruct them on how to live and manage their asthma day to day.<\/p>\n\n\n\n<p>\u201cAsthma control is still a struggle for many, though. So we\u2019re hoping to share some interesting ways to learn more about asthma control and how you can share that with your patients.\u201d<\/p>\n\n\n<style>.kb-image19370066_3c3e5d-d5 .kb-image-has-overlay:after{opacity:0.3;}<\/style>\n<figure class=\"wp-block-kadence-image kb-image19370066_3c3e5d-d5 size-large\"><img decoding=\"async\" width=\"1080\" height=\"572\" src=\"https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/09\/Summit_Scene_2023-1080x572.jpg\" alt=\"Photo of the USAsthma summit speaker presentation\" class=\"kb-img wp-image-1194\" title=\"\" srcset=\"https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/09\/Summit_Scene_2023-1080x572.jpg 1080w, https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/09\/Summit_Scene_2023-300x159.jpg 300w, https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/09\/Summit_Scene_2023-768x406.jpg 768w, https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/09\/Summit_Scene_2023.jpg 1200w\" sizes=\"(max-width: 1080px) 100vw, 1080px\" \/><\/figure>\n\n\n\n<p><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><b>Giving a Voice to Asthma Disparities through Education and Awareness,<\/b> Nancy Joseph, DO, USAsthma Summit Moderator, Board-certified in Pediatrics, Allergy and Immunology, Medical Advisor for Allergy &amp; Asthma Network<\/h2>\n\n\n<style>.kb-image19370066_5c380b-7b2.kb-image-is-ratio-size, .kb-image19370066_5c380b-7b2 .kb-image-is-ratio-size{max-width:300px;width:100%;}.wp-block-kadence-column > .kt-inside-inner-col > .kb-image19370066_5c380b-7b2.kb-image-is-ratio-size, .wp-block-kadence-column > .kt-inside-inner-col > .kb-image19370066_5c380b-7b2 .kb-image-is-ratio-size{align-self:unset;}.kb-image19370066_5c380b-7b2 figure{max-width:300px;}.kb-image19370066_5c380b-7b2 .image-is-svg, .kb-image19370066_5c380b-7b2 .image-is-svg img{width:100%;}.kb-image19370066_5c380b-7b2 .kb-image-has-overlay:after{opacity:0.3;}<\/style>\n<div class=\"wp-block-kadence-image kb-image19370066_5c380b-7b2\"><figure class=\"alignright size-full\"><img decoding=\"async\" width=\"600\" height=\"580\" src=\"https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/10\/Nancy-Joseph.jpg\" alt=\"Woman smiling and holding a microphone, wearing a tan blazer over a black outfit, standing on stage in front of a dark curtain.\" class=\"kb-img wp-image-19380125\" title=\"\" srcset=\"https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/10\/Nancy-Joseph.jpg 600w, https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/10\/Nancy-Joseph-300x290.jpg 300w\" sizes=\"(max-width: 600px) 100vw, 600px\" \/><\/figure><\/div>\n\n\n\n<p><b><i>8:40 mark in video<\/i><\/b><\/p>\n\n\n\n<p>The emergence of new asthma medications has led to remarkable progress in asthma care \u2013 but this progress is not reaching everyone. Dr. Joseph addressed ongoing <a href=\"https:\/\/allergyasthmanetwork.org\/health-equity\/\"><b>asthma disparities<\/b><\/a> in the United States \u2013 particularly those affecting the African American, Hispanic\/Latino and Native American communitie. She also cited the need for greater health equity.<\/p>\n\n\n\n<p>African Americans are&#8230;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>30% more likely to have asthma<\/li>\n\n\n\n<li>3 times more likely to have an emergency department visit due to asthma<\/li>\n\n\n\n<li>3 times more likely to die due to asthma<\/li>\n<\/ul>\n\n\n\n<p>In addition, African American children are 7 times more likely to die from asthma than their non-Hispanic white counterparts.<\/p>\n\n\n\n<p>Social determinants of health \u2013 nonmedical factors that influence health outcomes \u2013 \u201caffect every aspect of society,\u201d Dr. Joseph says.<\/p>\n\n\n\n<p>What can be done to advance health equity? Dr. Joseph cites raising awareness of the impact of asthma and allergic diseases on under-resourced communities. Patient advocacy for legislation and policies that support positive health outcomes and improve access to affordable and effective care is also essential for health equity.<\/p>\n\n\n\n<p>Allergy &amp; Asthma Network\u2019s <a href=\"https:\/\/allergyasthmanetwork.org\/news\/trusted-messengers-virtual-asthma-coaching\/\"><b>Trusted Messengers program <\/b><\/a>is an initiative designed to promote equity in healthcare. It is built on a belief in community-led solutions and involves partnerships with local churches, community groups, health centers and doctors. The program is designed to help people get the knowledge and care they need \u2013 from trusted, credible sources \u2013 to adopt healthy behaviors and make informed decisions about their health.<\/p>\n\n\n\n<p><a href=\"\/images\/USAsthma-summit\/02-2023-Giving-a-Voice-to-Asthma-Disparities.pdf\"><strong>Download the presentation<\/strong><\/a><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><b>Current State of Asthma in the United States<\/b>, Kathleen May, MD, President, American College of Allergy, Asthma &amp; Immunology<\/h2>\n\n\n<style>.kb-image19370066_d20f81-685.kb-image-is-ratio-size, .kb-image19370066_d20f81-685 .kb-image-is-ratio-size{max-width:300px;width:100%;}.wp-block-kadence-column > .kt-inside-inner-col > .kb-image19370066_d20f81-685.kb-image-is-ratio-size, .wp-block-kadence-column > .kt-inside-inner-col > .kb-image19370066_d20f81-685 .kb-image-is-ratio-size{align-self:unset;}.kb-image19370066_d20f81-685 figure{max-width:300px;}.kb-image19370066_d20f81-685 .image-is-svg, .kb-image19370066_d20f81-685 .image-is-svg img{width:100%;}.kb-image19370066_d20f81-685 .kb-image-has-overlay:after{opacity:0.3;}<\/style>\n<div class=\"wp-block-kadence-image kb-image19370066_d20f81-685\"><figure class=\"alignright size-full\"><img decoding=\"async\" width=\"600\" height=\"600\" src=\"https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/10\/DrMay-2.jpg\" alt=\"A woman stands at a podium with a microphone, presenting at the USAsthma Summit 2023. A large screen next to her displays a slide titled &quot;The State of Asthma in the United States.&quot; The setting is a conference room with dark curtains.\" class=\"kb-img wp-image-19380122\" title=\"\" srcset=\"https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/10\/DrMay-2.jpg 600w, https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/10\/DrMay-2-300x300.jpg 300w, https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/10\/DrMay-2-150x150.jpg 150w\" sizes=\"(max-width: 600px) 100vw, 600px\" \/><\/figure><\/div>\n\n\n\n<p><b><i>27:32 mark in video<\/i><\/b><\/p>\n\n\n\n<p>In September 2023, ACAAI, the American Academy of Allergy, Asthma &amp; Immunology (AAAAI) and the American Thoracic Society co-published a <a href=\"https:\/\/college.acaai.org\/new-definition-of-asthma-remission-on-treatment-developed\/\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><b>consensus statement on clinical remission of asthma<\/b><\/a>.<\/p>\n\n\n\n<p>During Dr. May\u2019s presentation at the USAsthma Summit, she further explained what allergists and pulmonologists could look for when evaluating asthma remission. The following would have to be met over a 12-month period by a patient undergoing biologic therapy:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>No asthma attacks requiring a physician visit, emergency care, hospitalization, and\/or oral corticosteroid use.<\/li>\n\n\n\n<li>No missed work or school days due to asthma.<\/li>\n\n\n\n<li>Stable and optimized pulmonary function, with a minimum of two measurements during the year.<\/li>\n<\/ul>\n\n\n\n<p>Other criteria would involve how often patients use certain therapies and results of asthma assessment questionnaires and\/or tools.<\/p>\n\n\n\n<p>The consensus statement on clinical remission of asthma does not create any change in how doctors currently treat patients, Dr. May emphasizes. It allows allergists and pulmonologists to gather more data, which will go toward developing guidance on asthma remission.<\/p>\n\n\n\n<p><a href=\"\/images\/USAsthma-summit\/03-2023-Current-State-of-Asthma.pdf\"><strong>Download the presentation<\/strong><\/a><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><b>The Impact of Social Media in Patient Care Decisions,<\/b> David Stukus, MD, Professor of Clinical Pediatrics, Division on Allergy and Immunology, The Ohio State University College of Medicine<\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full\"><img decoding=\"async\" width=\"417\" height=\"418\" src=\"https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/10\/Dave-Stukus.jpg\" alt=\"A speaker at a conference stands at a podium delivering a presentation titled &quot;The Impact of Social Media in Patient Care Decisions.&quot; The audience is seated, some with laptops open, in a dimly lit room.\" class=\"wp-image-19380121\" title=\"\" srcset=\"https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/10\/Dave-Stukus.jpg 417w, https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/10\/Dave-Stukus-300x300.jpg 300w, https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/10\/Dave-Stukus-150x150.jpg 150w\" sizes=\"(max-width: 417px) 100vw, 417px\" \/><\/figure><\/div>\n\n\n<p><b><i>1:10:48 mark in video<\/i><\/b><\/p>\n\n\n\n<p>Dr. Stukus examined the healthcare media landscape, which now includes content generated by artificial intelligence, or AI. He showed how opportunists are using social media to promote asthma cures, when no cure exists. And he provided some solutions to help healthcare professionals, patient advocacy groups and patients can get past misinformation:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Engage with patients and the public, even on social media. \u201cBecome an asthma myth-buster,\u201d Dr. Stukus says.<\/li>\n\n\n\n<li>Use technology and media platforms to share evidence-based information.<\/li>\n\n\n\n<li>Partner with community groups and local organizations.<\/li>\n<\/ul>\n\n\n\n<p>Dr. Stukus capped off his presentation by sharing a quote that was generated by AI: \u201cIt\u2019s essential for both patients and healthcare professionals to approach social media with critical thinking and verify information from reliable sources. While social media can offer valuable support and information, medical decisions should ultimately be based on evidence-based practices and advice from qualified healthcare providers.\u201d<\/p>\n\n\n\n<p><a href=\"\/images\/USAsthma-summit\/04-2023-The-Impact-of-Social-Media.pdf\"><strong>Download the presentation<\/strong><\/a><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>California Breathing and the Asthma Management Academy (AsMA) Model<\/strong>, Natalie Sacramento, MPH, California Department of Public Health.<\/h2>\n\n\n\n<p><b><i>2:09:40 mark in video<\/i><\/b><\/p>\n\n\n\n<p>Natalie Sacramento provided insight into asthma in California, site of the USAsthma Summit. Approximately 5.7 million people \u2013 about 1 in 7 \u2013 live with asthma in California.<\/p>\n\n\n\n<p>African American and Native American Californians are more likely to have severe asthma and die from asthma. Hispanic\/Latino Californians are less likely to have asthma than white Californians, but more likely to have severe asthma.<\/p>\n\n\n\n<p>Sacramento discussed the state\u2019s AsMA program, which trains community health workers to:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Provide evidence-based asthma self-management education, including proper technique and use of inhalers.<\/li>\n\n\n\n<li>Conduct an in-home asthma trigger assessment.<\/li>\n<\/ul>\n\n\n\n<p>Among people with poorly controlled asthma who took part in asthma education with community health workers:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>83% had reduced emergency department visits and hospitalizations;<\/li>\n\n\n\n<li>70% had fewer missed school or work days;<\/li>\n\n\n\n<li>70% had improved asthma control.<\/li>\n<\/ul>\n\n\n\n<p><a href=\"\/images\/USAsthma-summit\/05-2023-California-Breathing-and-Asthma-Management-Academy.pdf\"><strong>Download the presentation<\/strong><\/a><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><b>Asthma Medications and Management: Empowering Patients to Learn Their Options<\/b>, Corinne Young, MSN, FNP-C, FCCP, President of the Association of Pulmonary Advanced Practice Providers (APAPP); De De Gardner, DrPH, RRT, RRT-NPS, FAARC, FCCP, Chief Research Officer, Allergy &amp; Asthma Network<\/h2>\n\n\n\n<p><b><i>2:50:55 mark in video<\/i><\/b><\/p>\n\n\n\n<p>Corrine Young provided a closer look at available asthma combination treatments, including <a href=\"https:\/\/allergyasthmanetwork.org\/news\/asthma-smart-therapy\/\"><b>Single Maintenance and Reliever Therapy (SMART)<\/b><\/a>.<\/p>\n\n\n\n<p>SMART is a combination of an inhaled corticosteroid (budesonide) and long-acting beta-agonist (formoterol, an anti-inflammatory) using a single inhaler. It is for daily maintenance therapy and the relief of symptoms as needed. SMART allows moderate to severe asthma patients to get daily medicine to keep their airways open. If they experience symptoms, the anti-inflammatories help reduce airway inflammation.<\/p>\n\n\n\n<p>A new budesonide and albuterol combination is also available. It\u2019s a quick-relief and prevention medication for people 18 years or older with moderate to severe asthma. Research shows that combining these two medications reduces inflammation and helps stop the progression of an asthma attack.<\/p>\n\n\n\n<p>Allergy &amp; Asthma Network\u2019s De De Gardner presented research on the perception and use of <a href=\"https:\/\/allergyasthmanetwork.org\/what-is-asthma\/how-is-asthma-treated\/oral-corticosteroids-for-asthma\/\"><b>oral corticosteroids for asthma<\/b><\/a>. <b><i>(Note: slides are not available for this presentation.)<\/i><\/b><a href=\"https:\/\/allergyasthmanetwork.org\/what-is-asthma\/how-is-asthma-treated\/oral-corticosteroids-for-asthma\/\"><b><i>&nbsp;<\/i><\/b><\/a><\/p>\n\n\n\n<p>Many parents of children with asthma perceive oral corticosteroids as safe and they anticipate using them for asthma attacks. They were aware of the short-term side effects (weight gain, insomnia, mood changes), but not as familiar with long-term side effects (eye problems, diabetes onset, thinning bones and increased risk of infections).<\/p>\n\n\n\n<p>Parents recognize that biologics can decrease the frequency of asthma symptoms and reduce the need for oral corticosteroids. But the average out-of-pocket costs for biologics are $1,292.<\/p>\n\n\n\n<p><a href=\"\/images\/USAsthma-summit\/06-2023-Asthma-Medications-and-Management.pdf\"><strong>Download the presentation<\/strong><\/a><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><b>The Story of Tony<\/b>, Laonis Quinn, RN, MSN, AE-C. Founder, The Breathe Anthony J. Chapman Asthma Foundation.<\/h2>\n\n\n\n<p><b><i>4:31:40 mark in video<\/i><\/b><\/p>\n\n\n\n<p>Laonis Quinn of Detroit shared the store of her son Anthony J. Chapman, who passed away after a severe asthma attack in 2007.<\/p>\n\n\n\n<p>Anthony\u2019s asthma was mostly under control until his pulmonologist could no longer accept his health insurance provider. He had to turn to clinics that provided substandard care. His asthma flares worsened, leading to many emergency department visits.<\/p>\n\n\n\n<p>A year later, Anthony passed away at the age of 23. \u201cI still remember my scream, I still remember that moment \u2013 I\u2019ll always remember it. My life has been changed since that unthinkable day,\u201d Laonis says.<\/p>\n\n\n\n<p>Two years after Anthony\u2019s death, the Affordable Care Act was signed into law. If passed sooner, the measure would have allowed Anthony to stay on Laonis\u2019s health insurance through age 26. He would have been able to maintain his quality care.<\/p>\n\n\n\n<p>Laonis founded the <a href=\"https:\/\/breatheajcfoundation.org\/\" rel=\"noopener noreferrer nofollow\" target=\"_blank\"><b>Breathe Anthony J. Chapman Foundation<\/b><\/a> to share Anthony\u2019s story and raise awareness of the severity of asthma. She serves on the Board of Directors at Allergy &amp; Asthma Network.<\/p>\n\n\n\n<p><a href=\"\/images\/USAsthma-summit\/08-2023-The-Story-of-Tony.pdf\"><strong>Download the presentation<\/strong><\/a><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><b>Barriers to Medication Adherence in Asthma: The Importance of Culture and Context<\/b>, Elizabeth McQuaid, PhD, Vice Chair of Academic Affairs and Director of Child Psychology at Rhode Island Hospital\/Hasbro Children\u2019s Hospital; Director of the Division of Clinical Psychology, Vice Chair of the Department of Psychiatry and Human Behavior at Brown University.<\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/10\/Elizabeth-McQuaid-300x300-1.jpg\" alt=\"A person stands at a wooden podium with a sign that reads &quot;US Asthma Summit 2023.&quot; They are speaking into a microphone on a stage with a dark curtain and a screen displaying a partial image on the right.\" class=\"wp-image-19380123\" title=\"\" srcset=\"https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/10\/Elizabeth-McQuaid-300x300-1.jpg 300w, https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/10\/Elizabeth-McQuaid-300x300-1-150x150.jpg 150w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/figure><\/div>\n\n\n<p><b><i>4:50:35 mark in video<\/i><\/b><\/p>\n\n\n\n<p>Elizabeth McQuaid presented research on how <a href=\"https:\/\/allergyasthmanetwork.org\/health-equity\/\"><strong>health disparities<\/strong><\/a> and other barriers can affect medication use. \u201cConsistent medication use is necessary to control asthma, but most people don\u2019t take medication daily,\u201d she says.<\/p>\n\n\n\n<p>Why? Medication beliefs and use differ by race and ethnicity. Cultural beliefs, some of which have historical roots in mistreatment, can affect medication use. Provider bias can impact care. Research shows African American and Hispanic\/Latino patients are less often referred to asthma specialists compared to whites.<\/p>\n\n\n\n<p>Other cultural factors that impact adherence include age-based developmental transitions. For example, adolescents with asthma entering high school may be less inclined to follow their treatment play. In addition, some patients may turn to herbal remedies when they cannot access medicine, or in conjunction with medicine.<\/p>\n\n\n\n<p>Healthcare professionals can address medication barriers with open communication during office visits. Studies show digital devices, such as text messaging and mobile apps, can help motivate people to \u201ctake medication as directed,\u201d McQuaid said.<\/p>\n\n\n\n<p><a href=\"\/images\/USAsthma-summit\/09-2023-Barriers-to-Medication-Adherence-in-Asthma.pdf\"><strong>Download the presentation<\/strong><\/a><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><b>Indoor Air Quality: A Social Determinant of Health<\/b>, Sheila Brown, Project Analyst, U.S. Environmental Protection Agency (EPA); Anne Kelsey Lamb, MPH, Director, Regional Asthma Management &amp; Prevention (RAMP), A Project of the Public Health Institute<\/h2>\n\n\n\n<p><b><i>5:32:22 mark in video<\/i><\/b><\/p>\n\n\n\n<p>Sheila Brown and Anne Kelsey Lamb discussed how in-home and virtual environmental assessments and remediation can help people living with asthma.<\/p>\n\n\n\n<p>They introduced a new term \u2013 indoor environmental determinants of health, or IEDOH \u2013 to help identify indoor air factors that are fixable. These factors include household air pollution, the presence of pests, mold and moisture, chemicals and irritants.<\/p>\n\n\n\n<p>\u201cWe hope this terminology will help drive progress and action,\u201d Brown said. \u201cIt brings into focus the critical role of indoor air quality in asthma care.\u201d<\/p>\n\n\n\n<p>The RAMP program uses the proven intervention of asthma home visits and expands them to more under-resourced communities. This can help reduce asthma disparities. The program includes home trigger assessments, remediation supplies and services if needed, and comprehensive asthma education.<\/p>\n\n\n\n<p><a href=\"\/images\/USAsthma-summit\/10-2023-Indoor-Environmental-Determinants-of-Health.pdf\"><strong>Download the Sheila Brown presentation<\/strong><\/a><\/p>\n\n\n\n<p><a href=\"\/images\/USAsthma-summit\/11-2023-Addressing-Asthma-within-the-Context-of-IEDOH.pdf\"><strong>Download the Anne Kelsey Lamb presentation<\/strong><\/a><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"GINA-Updates\"><b>GINA 2023 Updates and the Future of Asthma Care<\/b>, Angela Hogan, MD; Children Hospital of the King\u2019s Daughters.<\/h2>\n\n\n\n<p><b><i>6:33:27 mark in video<\/i><\/b><\/p>\n\n\n\n<p>The Global Initiative for Asthma (GINA) updates its guidelines for asthma management every year. Dr. Hogan spotlighted some of the key changes in this year\u2019s GINA guidance.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The inhaled corticosteroid and formoterol combination inhaler is preferred for stepping up or stepping down asthma treatment. Studies show it is effective and safe, and it involves just one inhaler device. \u201cThis can help avoid confusion,\u201d Dr. Hogan says.<\/li>\n\n\n\n<li>The FDA-approved budesonide-albuterol combination is the first inhaled corticosteroid and short-acting beta-agonist on the market. It\u2019s prescribed for as-needed treatment and prevention of asthma symptoms in adults. It also involves just one device. The <a href=\"https:\/\/allergyasthmanetwork.org\/news\/mandala-study-asthma-albuterol-budesonide\/\"><b>MANDALA study<\/b><\/a> showed the budesonide-albuterol combo prevented asthma attacks better than albuterol alone.<a href=\"https:\/\/allergyasthmanetwork.org\/news\/mandala-study-asthma-albuterol-budesonide\/\">&nbsp;<\/a><\/li>\n\n\n\n<li>Biologic therapy for asthma should only be prescribed when asthma is severe and other treatment options have been considered. \u201cGINA is saying we should not escalate to biologics until it\u2019s proven the patient has severe asthma,\u201d Dr. Hogan says.<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Doctors can consider a short course of an inhaled corticosteroid for children 5 years of age and under who are wheezing regularly as a result of a viral illness.<\/li>\n\n\n\n<li>Patients should have two asthma inhalers, if possible. Keep one at home and one in a backpack or bag that you carry with you away from home.<\/li>\n\n\n\n<li>As SMART becomes more commonly used in asthma treatment, doctors and patients should consider developing a SMART Asthma Action Plan.<\/li>\n<\/ul>\n\n\n\n<p><a href=\"\/images\/USAsthma-summit\/12-2023-GINA-2023-Updates.pdf\"><strong>Download the presentation<\/strong><\/a><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><b>EPA Award Winner: The Wisconsin Asthma Program. How Collaboration, Data, Equity Goals (And Perseverance) Improve Asthma Outcomes in Wisconsin,<\/b> Erika Kluetmeier, Environmental Health Communications Strategist, Wisconsin Department of Health Services<\/h2>\n\n\n\n<p><b><i>7:23:15 mark in video<\/i><\/b><\/p>\n\n\n\n<p>Each year, EPA awards the National Environmental Leadership Award in\u202fAsthma Management. The 2023 winner is the <a href=\"https:\/\/www.epa.gov\/asthma\/national-environmental-leadership-award-asthma-management\" rel=\"noopener noreferrer nofollow\" target=\"_blank\"><b>Wisconsin Department of Health Services\u2019<\/b> <b>Asthma Program<\/b><\/a><b>.<\/b><\/p>\n\n\n\n<p>The Wisconsin Department of Health Services\u2019 Asthma Program successfully delivers high quality asthma care statewide by building strong community ties, integrating healthcare services, and tailoring environmental interventions. Serving nearly 6 million state residents, the program activities focus on disproportionately affected populations including children, people with low income, and racial and ethnic minorities.<\/p>\n\n\n\n<p>The Wisconsin Asthma Program involves strong partnerships with community organizations and innovative projects, including the Asthma-Safe Homes Program. The program builds upon a pilot asthma home-visiting program, the result of a collaboration with Medicaid to provide sustainable asthma funding.<\/p>\n\n\n\n<p><a href=\"\/images\/USAsthma-summit\/13-2023-EPA-Award-Winners.pdf\"><strong>Download the presentation<\/strong><\/a><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\"><img decoding=\"async\" width=\"1080\" height=\"572\" src=\"https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/10\/USAsthma_Group_shot-1080x572.jpg\" alt=\"A group of ten people stand indoors, smiling, and holding a sign that reads &quot;USAsthma Summit 2023.&quot; The sign displays logos for sponsors AMGEN, Sanofi, AstraZeneca, and Regeneron. They are dressed in business casual attire.\" class=\"wp-image-19380127\" title=\"\" srcset=\"https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/10\/USAsthma_Group_shot-1080x572.jpg 1080w, https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/10\/USAsthma_Group_shot-300x159.jpg 300w, https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/10\/USAsthma_Group_shot-768x406.jpg 768w, https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/10\/USAsthma_Group_shot.jpg 1200w\" sizes=\"(max-width: 1080px) 100vw, 1080px\" \/><\/figure><\/div>\n\n\n<p><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p><b>We are incredibly grateful to ACAAI for their support and the meeting space for the USAsthma Summit. We are also incredibly grateful to our corporate partners who\u2019s sponsorship of USAsthma funded the program as well as the scholarships offered to 50 in-person attendees.<\/b><\/p>\n\n\n\n<p class=\"has-text-align-center\"><em>Sponsored by:<\/em><\/p>\n\n\n<style>.kb-image19370066_410093-55.kb-image-is-ratio-size, .kb-image19370066_410093-55 .kb-image-is-ratio-size{max-width:200px;width:100%;}.wp-block-kadence-column > .kt-inside-inner-col > .kb-image19370066_410093-55.kb-image-is-ratio-size, .wp-block-kadence-column > .kt-inside-inner-col > .kb-image19370066_410093-55 .kb-image-is-ratio-size{align-self:unset;}.kb-image19370066_410093-55 figure{max-width:200px;}.kb-image19370066_410093-55 .image-is-svg, .kb-image19370066_410093-55 .image-is-svg img{width:100%;}.kb-image19370066_410093-55 .kb-image-has-overlay:after{opacity:0.3;}<\/style>\n<div class=\"wp-block-kadence-image kb-image19370066_410093-55\"><figure class=\"aligncenter size-full\"><img decoding=\"async\" width=\"400\" height=\"97\" src=\"https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/10\/Amgen_logo_400x97-1.jpg\" alt=\"Blue text logo of the company &quot;AMGEN&quot; with a registered trademark symbol in the upper right corner. The lettering is bold and in uppercase.\" class=\"kb-img wp-image-19380119\" title=\"\" srcset=\"https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/10\/Amgen_logo_400x97-1.jpg 400w, https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/10\/Amgen_logo_400x97-1-300x73.jpg 300w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/figure><\/div>\n\n\n<style>.kb-image19370066_a40ce4-49.kb-image-is-ratio-size, .kb-image19370066_a40ce4-49 .kb-image-is-ratio-size{max-width:235px;width:100%;}.wp-block-kadence-column > .kt-inside-inner-col > .kb-image19370066_a40ce4-49.kb-image-is-ratio-size, .wp-block-kadence-column > .kt-inside-inner-col > .kb-image19370066_a40ce4-49 .kb-image-is-ratio-size{align-self:unset;}.kb-image19370066_a40ce4-49 figure{max-width:235px;}.kb-image19370066_a40ce4-49 .image-is-svg, .kb-image19370066_a40ce4-49 .image-is-svg img{width:100%;}.kb-image19370066_a40ce4-49 .kb-image-has-overlay:after{opacity:0.3;}<\/style>\n<div class=\"wp-block-kadence-image kb-image19370066_a40ce4-49\"><figure class=\"aligncenter size-full\"><img decoding=\"async\" width=\"400\" height=\"235\" src=\"https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/10\/Astra-Zeneca-logo.jpg\" alt=\"The image shows the AstraZeneca logo, featuring an abstract yellow symbol above the company name &quot;AstraZeneca&quot; written in purple text.\" class=\"kb-img wp-image-19380120\" title=\"\" srcset=\"https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/10\/Astra-Zeneca-logo.jpg 400w, https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/10\/Astra-Zeneca-logo-300x176.jpg 300w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/figure><\/div>\n\n\n<style>.kb-image19370066_b1e019-f1.kb-image-is-ratio-size, .kb-image19370066_b1e019-f1 .kb-image-is-ratio-size{max-width:175px;width:100%;}.wp-block-kadence-column > .kt-inside-inner-col > .kb-image19370066_b1e019-f1.kb-image-is-ratio-size, .wp-block-kadence-column > .kt-inside-inner-col > .kb-image19370066_b1e019-f1 .kb-image-is-ratio-size{align-self:unset;}.kb-image19370066_b1e019-f1 figure{max-width:175px;}.kb-image19370066_b1e019-f1 .image-is-svg, .kb-image19370066_b1e019-f1 .image-is-svg img{width:100%;}.kb-image19370066_b1e019-f1 .kb-image-has-overlay:after{opacity:0.3;}<\/style>\n<div class=\"wp-block-kadence-image kb-image19370066_b1e019-f1\"><figure class=\"aligncenter size-full\"><img decoding=\"async\" width=\"300\" height=\"106\" src=\"https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2025\/05\/gsk.jpg\" alt=\"The image shows the GSK logo in bold, uppercase letters with a gradient orange color on a white background.\" class=\"kb-img wp-image-19387224\" title=\"\"><\/figure><\/div>\n\n\n<style>.kb-image19370066_38daed-0f.kb-image-is-ratio-size, .kb-image19370066_38daed-0f .kb-image-is-ratio-size{max-width:500px;width:100%;}.wp-block-kadence-column > .kt-inside-inner-col > .kb-image19370066_38daed-0f.kb-image-is-ratio-size, .wp-block-kadence-column > .kt-inside-inner-col > .kb-image19370066_38daed-0f .kb-image-is-ratio-size{align-self:unset;}.kb-image19370066_38daed-0f figure{max-width:500px;}.kb-image19370066_38daed-0f .image-is-svg, .kb-image19370066_38daed-0f .image-is-svg img{width:100%;}.kb-image19370066_38daed-0f .kb-image-has-overlay:after{opacity:0.3;}<\/style>\n<div class=\"wp-block-kadence-image kb-image19370066_38daed-0f\"><figure class=\"aligncenter size-full\"><img decoding=\"async\" width=\"1024\" height=\"144\" src=\"https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/10\/Sanofi_Regeneron_Logo_1024.webp\" alt=\"Logos of two companies: Sanofi with black text and a purple dot over the &#039;i&#039;, and Regeneron in blue, uppercase letters. Both logos are separated by a vertical line. The image has a transparent background.\" class=\"kb-img wp-image-19380126\" title=\"\" srcset=\"https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/10\/Sanofi_Regeneron_Logo_1024.webp 1024w, https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/10\/Sanofi_Regeneron_Logo_1024-300x42.webp 300w, https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/10\/Sanofi_Regeneron_Logo_1024-768x108.webp 768w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><\/div>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Hear from asthma specialists and state asthma programs on how to improve access to asthma management and treatment.<\/p>\n","protected":false},"author":1,"featured_media":1194,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"footnotes":""},"categories":[2,43],"tags":[],"class_list":["post-19370066","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-advocacy-updates"],"taxonomy_info":{"category":[{"value":2,"label":"News"},{"value":43,"label":"Advocacy"}]},"featured_image_src_large":["https:\/\/allergyasthmanetwork.org\/wp-content\/uploads\/2024\/09\/Summit_Scene_2023-1080x572.jpg",1080,572,true],"author_info":{"display_name":"Allergy &amp; Asthma Network","author_link":"https:\/\/allergyasthmanetwork.org\/author\/kolleen\/"},"comment_info":0,"category_info":[{"term_id":2,"name":"News","slug":"news","term_group":0,"term_taxonomy_id":2,"taxonomy":"category","description":"Allergy &amp; Asthma Network keeps you up to date with the latest news, information and patient education addressing asthma, allergies and related conditions. Read the latest press releases and learn about our initiatives in advocacy on the federal, state and local levels. Get information on the Network\u2019s research projects and how you can get involved.","parent":0,"count":462,"filter":"raw","cat_ID":2,"category_count":462,"category_description":"Allergy &amp; Asthma Network keeps you up to date with the latest news, information and patient education addressing asthma, allergies and related conditions. Read the latest press releases and learn about our initiatives in advocacy on the federal, state and local levels. Get information on the Network\u2019s research projects and how you can get involved.","cat_name":"News","category_nicename":"news","category_parent":0},{"term_id":43,"name":"Advocacy","slug":"advocacy-updates","term_group":0,"term_taxonomy_id":43,"taxonomy":"category","description":"Allergy &amp; Asthma Network works to help Americans with asthma, allergies and related conditions at the federal, state and local level. Making sure the patient\u2019s voice is heard in legislation and policy issues is an important part of the Network\u2019s advocacy work. Advocates play a crucial role in raising awareness, educating policymakers and the general public, removing barriers to care and making issues widely known to make medical care and treatment more accessible and effective. One key advocacy initiative is to ensure people living with asthma disparities have equal access to high-quality and affordable care.\n\nThe COVID-19 pandemic has brought new healthcare issues to the forefront, such as H.R. 7647, the \u201cPreserving Patient Savings on Drug Costs Act.\u201d This legislation delays increasing medication costs for a year after the pandemic ends, putting a cap on out-of-pocket costs, and allow drug-sharing coupons to count towards deductibles. It highlights the importance of all patients to get the medicine they need during the COVID-19 health crisis.","parent":0,"count":52,"filter":"raw","cat_ID":43,"category_count":52,"category_description":"Allergy &amp; Asthma Network works to help Americans with asthma, allergies and related conditions at the federal, state and local level. Making sure the patient\u2019s voice is heard in legislation and policy issues is an important part of the Network\u2019s advocacy work. Advocates play a crucial role in raising awareness, educating policymakers and the general public, removing barriers to care and making issues widely known to make medical care and treatment more accessible and effective. One key advocacy initiative is to ensure people living with asthma disparities have equal access to high-quality and affordable care.\n\nThe COVID-19 pandemic has brought new healthcare issues to the forefront, such as H.R. 7647, the \u201cPreserving Patient Savings on Drug Costs Act.\u201d This legislation delays increasing medication costs for a year after the pandemic ends, putting a cap on out-of-pocket costs, and allow drug-sharing coupons to count towards deductibles. It highlights the importance of all patients to get the medicine they need during the COVID-19 health crisis.","cat_name":"Advocacy","category_nicename":"advocacy-updates","category_parent":0}],"tag_info":false,"meta_box":{"start_date":"","end_date":""},"_links":{"self":[{"href":"https:\/\/allergyasthmanetwork.org\/wp-json\/wp\/v2\/posts\/19370066","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/allergyasthmanetwork.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/allergyasthmanetwork.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/allergyasthmanetwork.org\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/allergyasthmanetwork.org\/wp-json\/wp\/v2\/comments?post=19370066"}],"version-history":[{"count":0,"href":"https:\/\/allergyasthmanetwork.org\/wp-json\/wp\/v2\/posts\/19370066\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/allergyasthmanetwork.org\/wp-json\/wp\/v2\/media\/1194"}],"wp:attachment":[{"href":"https:\/\/allergyasthmanetwork.org\/wp-json\/wp\/v2\/media?parent=19370066"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/allergyasthmanetwork.org\/wp-json\/wp\/v2\/categories?post=19370066"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/allergyasthmanetwork.org\/wp-json\/wp\/v2\/tags?post=19370066"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}